Microferrum (ferrous fumarate)

Quick links

Choose a section

Quick links to important sections

Advertisements

Microferrum (ferrous fumarate)

Advertisements
Advertisements

Overview of Microferrum (ferrous fumarate)

Composition and Classification

Ferrous fumarate, the active compound in products such as Microferrum, is chemically classified as a synthetic iron salt intended for oral administration. It functions as a single-ingredient product within the pharmacological class of hematinics or oral iron supplements. The medication’s core purpose is to deliver bivalent iron (Fe^2+) to the body. Within international classification systems, it is categorized specifically as an oral bivalent iron preparation.

The compound is utilized in supplementation because, upon ingestion, it provides ferrous ions (Fe^2+), which the small intestine is biologically structured to absorb. Due to its solubility and elemental iron content, it is an established choice for iron replacement therapy. This iron salt is typically prepared as a concentrated source of iron delivered in an oral format, such as tablets, capsules, or suspensions.

General Purpose: Supporting Essential Oxygen Transport

The primary role of this mineral iron preparation is to assist in maintaining and restoring iron stores throughout the body. Absorbed iron serves as an essential building block for hemoglobin synthesis and erythropoiesis (the production of red blood cells).

By facilitating a sufficient supply of this trace element, the medication supports the physiological function of oxygen transport within the circulatory system, which is necessary for tissue health and cellular energy production. Common applications for this type of iron supplement include general supplementation for individuals with increased physiological requirements or to address confirmed lower-than-normal iron levels.

Regulatory References

  1. NIH MedlinePlus on Iron
Advertisements

What side effects are possible with Microferrum (ferrous fumarate)?

Possible side effects and safety information

The safety profile of ferrous fumarate, an oral iron salt, is primarily characterized by adverse reactions within the Gastrointestinal disorders system-organ class, as documented in official regulatory labeling.

Adverse Reactions and Frequency Classification

The most frequently observed effects are classified as common (occurring in 1 to 10 out of every 100 patients) and include nausea, epigastric pain, constipation, and diarrhea. The discoloration of stools to a black or dark color is a very common and expected, yet benign, consequence of taking oral iron supplements. Other gastrointestinal effects, such as vomiting and abdominal discomfort or distension, are also documented, with frequency sometimes classified as not known.

Reactions within the Immune system disorders class, such as allergic reactions (including rash or itching), are classified as rare (occurring in less than 1 out of every 1,000 patients).

Serious Adverse Reactions and Safety Constraints

Regulatory documents highlight the potential for serious adverse reactions, including signs of systemic allergic response, such as difficulty breathing, or indications of severe gastrointestinal distress, such as bloody or tarry stools. Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children younger than 6 years, necessitating the critical warning that the product must be kept out of the sight and reach of children.

Use is contraindicated (restricted) in individuals with certain pre-existing conditions, including iron-overload syndromes like hemochromatosis or hemosiderosis, as well as active inflammatory conditions of the gastrointestinal tract, such as an active peptic ulcer.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information describes overdose with iron-containing products, such as ferrous fumarate, as a potentially life-threatening event requiring immediate medical attention. The initial manifestations documented in official labels often involve severe gastrointestinal symptoms, including vomiting, diarrhea, abdominal pain, hematemesis (vomiting blood), and melena (black stools).

Overdose can progress rapidly to systemic multi-organ toxicity, leading to severe complications such as low blood pressure (hypotension), shock, metabolic acidosis, convulsions, and central nervous system depression, potentially progressing to coma. Documented life-threatening outcomes include acute hepatic failure and cardiovascular collapse.

Required Emergency Actions

The FDA and other government health authorities mandate specific emergency actions. You must seek immediate medical attention or call a poison control center immediately if overdose is suspected. Urgent medical intervention, including calling emergency services, is required if the person has collapsed, had a seizure, has trouble breathing, or can't be awakened.

Population-Specific Risk

Regulatory warnings state that accidental overdose of iron-containing products is the leading cause of fatal poisoning in children under six. For severe toxicity, the specific chelating agent Deferoxamine is listed for use in medical settings, along with supportive procedures like whole-bowel irrigation and continuous monitoring.

Advertisements

Therapeutic Uses of Microferrum (ferrous fumarate)

Main Uses of Microferrum (ferrous fumarate)

Microferrum is a medicinal product containing ferrous fumarate, a type of iron salt used to address specific nutritional and physiological needs related to iron levels in the body. Its primary applications focus on restoring and maintaining healthy iron stores.

Treatment of Iron Deficiency Anemia

The principal use of Microferrum is the treatment of iron deficiency anemia. This condition occurs when the body lacks sufficient iron to produce adequate amounts of hemoglobin, the protein in red blood cells responsible for carrying oxygen to tissues and organs. By providing a concentrated source of elemental iron, Microferrum helps the body synthesize new red blood cells and increase hemoglobin levels.

Prevention of Iron Deficiency

Microferrum is also used as a preventative measure for individuals at a high risk of developing iron depletion. This includes various groups who may have increased physiological demands or limited dietary intake, such as:

  • Individuals with increased iron requirements: Certain life stages or physical conditions can lead to a higher demand for iron that may not be met by diet alone.
  • Individuals with inadequate dietary intake: Those whose nutritional habits do not provide sufficient iron-rich foods may use this supplement to maintain healthy levels.
  • Malabsorption issues: It may be used when the body has difficulty absorbing enough iron from standard food sources.

Benefits of Maintaining Iron Levels

Restoring iron levels through the use of ferrous fumarate provides several physiological benefits derived from the correction of iron deficiency.

Restoration of Energy and Reduction of Fatigue

Iron is a critical component of energy metabolism. Correcting a deficiency often leads to a noticeable reduction in the persistent tiredness and lethargy associated with anemia, as the body's cells receive a more consistent supply of oxygen.

Support for Cognitive Function

Adequate iron levels are necessary for optimal brain function. Maintaining these levels can support concentration, memory, and general mental clarity, which are often impaired when iron stores are low.

Support for the Immune System

Iron plays a role in the proper functioning of the immune system. Ensuring the body has sufficient iron helps maintain the natural defense mechanisms against various stressors.

Physical Performance and Temperature Regulation

Healthy iron levels support physical endurance and the body's ability to regulate its internal temperature. By ensuring efficient oxygen transport to the muscles, iron helps maintain physical capacity during exertion.

Regulatory References

  1. NIH StatPearls guide on Iron Supplementation
Advertisements

Eligibility and Restrictions for Use

Who can and cannot use Microferrum (ferrous fumarate)?

Ferrous fumarate is intended for use in individuals with iron-deficiency anemia and is generally allowed for adults. Pediatric use is permitted when specifically recommended by a healthcare professional.

Use of this medicine is strictly prohibited (contraindicated) in several patient populations due to the risk of serious complications. These include individuals with iron overload conditions, such as hemochromatosis or haemosiderosis. It must also not be used in patients with anaemias other than those caused by iron deficiency, such as hemolytic anemia or pernicious anemia.

Contraindications also apply to individuals with certain active, pre-existing gastrointestinal conditions, specifically active peptic ulceration, ulcerative colitis, or regional enteritis. Patients undergoing repeated blood transfusions are also contraindicated, as are those with a known hypersensitivity to the formulation's ingredients.

Pregnancy and Lactation: Official regulatory guidance states that ferrous fumarate can be used during pregnancy and breast-feeding if clinically indicated. It is considered safe for the mother and is not shown to cause adverse effects in breastfed infants.

Advertisements

What should I know about interactions with other medicines?

Microferrum (ferrous fumarate) Interactions with other medicines and products

The official regulatory profile for ferrous fumarate is defined by interactions that primarily affect absorption in the gastrointestinal tract due to the chemical nature of the iron cation.

Exposure-Altering Interactions

The presence of the ferrous ion (Fe²⁺) can lead to decreased systemic exposure of several co-administered medicinal products, as documented in official prescribing information. These products include Levothyroxine (thyroid hormone replacement), certain Quinolone and Tetracycline antibiotics, Bisphosphonates (e.g., Alendronate), and anti-Parkinson agents like Levodopa. Conversely, acid-reducing agents such as Antacids and Proton Pump Inhibitors (PPIs) may reduce the absorption and bioavailability of the oral iron supplement itself.

Interaction-Related Constraints

To mitigate absorption interference, regulatory documents mandate specific timing separation for administration. Ferrous fumarate must be taken at least four hours apart from Levothyroxine, and typically separated by two to six hours from Quinolone antibiotics. Administration should also be separated by at least two hours from Antacids and Calcium supplements. The combination of oral iron with Dimercaprol is officially restricted due to the documented risk of enhanced nephrotoxicity. Furthermore, tea, coffee, and dairy products can reduce iron absorption and should be avoided close to dosing.

Advertisements

Mechanism of Action

The mechanism initiates with the delivery of the highly available ferrous ion (Fe^2+), which is actively transported across the intestinal barrier primarily via the membrane protein Divalent Metal Transporter 1 (DMT1), bypassing the variability of dietary iron intake. This initial process is the rate-limiting step for systemic supply and determines the iron substrate availability for all subsequent biological functions.

Once absorbed, the iron is routed to the bone marrow, where it serves as the critical metallic cofactor for the synthesis of Heme, which is then incorporated into the Hemoglobin molecule. By enabling this structural incorporation, the drug engages the entire Erythropoiesis pathway, which increases the concentration of functional Hemoglobin and defines the blood's oxygen-carrying capacity.

The efficacy of the transport mechanism is dynamically constrained by the regulatory peptide Hepcidin, which downregulates iron export via Ferroportin in response to inflammation. This feedback regulation prevents excessive iron release. In parallel, the continuous provision of iron supports the function of iron-dependent enzymes (e.g., cytochromes) crucial for cellular respiration and metabolic health. The action is characterized by elemental delivery and structural incorporation, enabling key biological pathways to function.

Advertisements

Dosage and Administration Information

How Microferrum (ferrous fumarate) is Used: Official Instructions

Ferrous fumarate is an Oral iron supplement, and its administration follows established protocols to ensure proper absorption.


Official Dosing and Frequency

Population Elemental Iron Range (Daily) Typical Frequency
Adult Treatment 100 mg to 200 mg Once, twice, or three times daily
Adult Prophylaxis 60 mg to 120 mg Once or twice daily
Pediatric Dosing 3–6 mg/kg/day (Elemental Iron) Divided doses (e.g., once to three times daily)

For some strengths, the usual adult dose is one tablet (e.g., 200 mg to 325 mg ferrous fumarate) taken one to three times per day. The treatment course often continues for 3 to 6 months to replenish the body's iron stores, even after blood levels have normalized. A physician may advise taking the dose on alternate days to enhance absorption or improve tolerability.


Administration Requirements

Timing and Absorption: The medication is best absorbed when taken on an empty stomach, approximately 1 hour before or 2 hours after a meal. If stomach upset occurs, the dose may be taken with or just after food to mitigate gastrointestinal effects, though this may decrease iron uptake.

Special Conditions:

  • Swallow whole: Tablets and capsules must be swallowed whole with water or juice; they should not be crushed, chewed, or sucked.
  • Inhibitors: Avoid taking the supplement with milk, tea, coffee, or antacids for at least 2 hours, as these substances can significantly reduce the amount of iron absorbed.
  • Missed Dose: If a dose is missed, take the next dose at the regular time. Do not take two doses together to make up for a single missed dose.
Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies for Microferrum (ferrous fumarate)


Evidence for use in Iron Deficiency Anemia

This section will summarize studies, including randomized trials, that have evaluated Microferrum (ferrous fumarate) and examined how changes in iron levels and outcomes related to physical discomfort were observed in adults with iron deficiency anemia. Research examined Microferrum in individuals diagnosed with iron deficiency anemia, a condition marked by functional limitations and outcomes related to systemic or functional imbalance. The findings describe patterns observed in the studies where individuals receiving ferrous fumarate were monitored for changes in blood iron markers and outcomes related to physical discomfort. Research has explored whether Microferrum is associated with differences in the rate of change of iron stores when compared with placebo. The results apply only to the populations studied, and data are still emerging regarding the overall patterns over extended time periods.


Evidence for use in Iron Deficiency During Pregnancy

This section will outline the research evidence focusing on research where Microferrum (ferrous fumarate) was studied for conditions associated with acute or disruptive episodes of iron deficiency in pregnant individuals. Research explored the use of ferrous fumarate in outcomes related to systemic or functional imbalance for the mother, as well as outcomes for the baby related to iron levels at birth. The findings describe patterns observed in the studies where use of ferrous fumarate was evaluated in relation to changes in iron levels during pregnancy. Evidence quality varies across studies, and certainty remains low for many of the comparative questions.


Long-term Studies and Follow-up

Research has been studied for the long-term aspects of Microferrum (ferrous fumarate), but there is limited information for long-term outcomes. The available evidence contributes to understanding symptom patterns related to long-term iron levels. Follow-up durations were limited in most trials, meaning that long-term effects are not fully established regarding the status of iron levels in follow-up years later.


Evidence in Special Populations

Microferrum was studied for use in populations such as children and older adults. Research examined its use in children, focusing on outcomes related to systemic or functional imbalance. The research describes that the overall patterns observed appear to align with those in younger adults, but subgroup findings are uncertain due to sample sizes being modest.


What is Still Uncertain About Microferrum (ferrous fumarate)

Certainty remains low in several areas where research is ongoing. Comparative evidence is lacking to establish the long-term differences in patient-reported outcomes describing perceived discomfort when compared against every other agent evaluated in this context. Evidence is limited regarding its use in individuals with certain conditions marked by functional limitations.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Microferrum (ferrous fumarate) (FAQ)

Q: What should a user expect regarding physical changes in the first week of taking Microferrum?

Official product information indicates that in the first few days of using Microferrum, it is common to experience gastrointestinal effects like nausea, constipation, diarrhea, and abdominal discomfort. Stool discoloration to a black or dark color is a normal and expected consequence of taking oral iron supplements.

Q: Do experts recommend Microferrum for long-term use?

According to official regulatory guidance, the typical treatment course is often continued for three to six months. This duration is intended to replenish the body's iron stores, even after blood levels have returned to the normal range. Use beyond this timeframe is generally subject to professional evaluation.

Q: Is Microferrum a medicine that requires a prescription?

The dispensing status of ferrous fumarate can vary depending on the specific product formulation and its elemental iron content. Some versions are categorized by regulatory bodies as prescription-only (Rx) drugs. Other preparations that contain ferrous fumarate may be marketed as non-prescription supplements.

Q: What kind of supplements should generally be avoided while using Microferrum?

Official sources highlight that certain mineral supplements should be noted when taking Microferrum, as the absorption of the iron can be interfered with by minerals such as calcium, magnesium, or zinc. Official guidance exists regarding the co-administration of other iron-containing products.

Q: Is it true that taking Microferrum with Vitamin C can help?

Official product labels show that many formulations of ferrous fumarate are co-formulated with ascorbic acid (Vitamin C) as an ingredient. The inclusion of Vitamin C in these specialized products is noted in product information.

Q: Does Microferrum contain common allergens like gluten or lactose?

The official product information for Microferrum lists the active ingredient and all inactive ingredients (excipients). The full list of ingredients can be found on the product's label or package insert, as formulations can vary between manufacturers.

Q: What happens in the body if too much Microferrum is accidentally taken?

Official safety information warns that accidental overdose of iron-containing products is a leading cause of fatal poisoning in young children. Symptoms of an overdose in the body include severe gastrointestinal distress, such as nausea, vomiting, abdominal pain, diarrhea, and potentially vomiting of blood or rectal bleeding.

Q: Are there specific safety warnings for older adults using Microferrum?

Regulatory documents and professional monographs caution that anemia in older adults often stems from causes other than simple iron deficiency, such as inflammation or chronic disease. This highlights why an assessment of iron stores is relevant before iron treatment in this population.

Q: Is a metallic taste in the mouth sometimes associated with Microferrum use?

Official adverse reaction reports for oral iron supplements indicate that taste perversion is a possible effect. This symptom is often perceived by users as a metallic taste in the mouth.

Q: Is Microferrum considered a slow-release iron supplement?

Regulatory guidance suggests that immediate-release oral iron products are generally the preferred form for treating iron deficiency. Although ferrous fumarate can be found in various forms, slow-release or enteric-coated versions are sometimes not recommended due to concerns about reduced absorption of the iron.

Advertisements

How should Microferrum (ferrous fumarate) be stored and disposed of?

How to Store and Dispose of Microferrum (Ferrous Fumarate)

Ferrous fumarate products must be stored at Controlled Room Temperature, typically between 20^circ to 25 C (68^circ to 77 F), with excursions permitted up to 30 C. The medication must be protected from light and moisture and stored away from excessive heat; do not freeze.

It is mandatory to keep the product in its original container, tightly closed. Due to the risk of fatal pediatric iron poisoning, the medication must be kept out of the sight and reach of children and safety caps must always be locked.

For disposal, do not flush the medication down the toilet or throw it into household waste. Unused or expired product should be discarded via a medicine take-back program or according to local regulations for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Microferrum (ferrous fumarate) found in:

A-Z Index: